Proposed Legislation Would Help FDA Stop Illicit Opioids At Border -- And More
Executive Summary
US FDA would gain more of the ability it seeks to interdict illicit opioids at the border under legislation proposed by House Energy & Commerce Committee's top Democrat. But would there be collateral damage to the legitimate pharmaceutical industry?
You may also be interested in...
Opioids: US Senate Committee Chairman's Discussion Drafts Broadly Reflect FDA Priorities
Agency would be allowed to require blister packaging for approved opioids, and would have to do more to coordinate with US Customs and Border Protection to detect illicit drugs at the border, under legislative proposals unveiled by Senate HELP Committee Chairman Lamar Alexander.
Bipartisan Consensus Emerges To Let FDA Destroy Unlabeled Illicit Opioids
Congress is intent on passing legislation addressing the opioid crisis and one measure that is picking up steam would give FDA the authority to destroy illegal opioids at international mail facilities instead of sending them back.
Gottlieb's Priority For Proposed Opioid Money Is Mail Facilities
US FDA commissioner says primary use of proposed budget boost would be border security; budget documents state that special opioid epidemic funding also would support regulatory science and diagnostic development.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: